Wire · opportunities
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 30 September 2026 · Fusion42 review
Ceribell has received FDA 510(k) clearance for new quantitative EEG trending and amplitude-integrated EEG analysis software, enhancing the Ceribell System with easier and faster brain activity interpretation for clinicians. The software update includes Alpha-Delta Ratio and Relative Alpha trending, Burst Suppression monitoring, and amplitude-integrated EEG, applicable across all ages in acute care settings.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
You can now develop or integrate simpler, faster EEG brain monitoring tools for both neonatal and adult acute care without age restrictions, opening new clinical adoption routes in hospitals across the US. This clearance reduces the barrier for bedside brain monitoring innovation and speeds time to treatment decisions in neurological care.
◆ Coverage
1 source · 30 Sep 2026
◆ Related on Wire
◆ Topics